Israeli cannabis firm Kanabo to be bought by London's Spinnaker

Euronews logo
Text size Aa Aa

(Reuters) – Israel’s Kanabo Research has agreed to be bought by cash shell Spinnaker Opportunities <SOP.L>, in what could lead to the first listing of a cannabis company on London’s main stock market.

In a statement on Monday, Spinnaker did not disclose the value of the proposed reverse takeover, which would allow Tel Aviv-based Kanabo to bypass traditional listing rules.

The companies did not immediately respond to requests for comment on the value.

Spinnaker has also agreed to pump in 200,000 pounds ($256,600.00) into Kanabo, which is looking to grow sales. The Israeli company already has a promise of 1.4 million pounds from the London-listed firm.

Kanabo supplies medical cannabis products that do not contain THC, the psychoactive ingredient in marijuana which causes hallucinations. Its products are delivered through a vaping device.

The London Stock Exchange has not seen many pot firms in its indexes. GW Pharmaceuticals <GWPH.O>, which makes marijuana-based epilepsy treatments, was listed on the bourse’s junior market between 2001 and 2016.

(Reporting by Pushkala Aripaka and Noor Zainab Hussain in Bengaluru; Editing by Maju Samuel)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.
Euronews is no longer accessible on Internet Explorer. This browser is not updated by Microsoft and does not support the last technical evolutions. We encourage you to use another browser, such as Edge, Safari, Google Chrome or Mozilla Firefox.